Pasquale Perrone Filardi – författare

This issue of Heart Failure Clinics, Guest Edited by Dr.�Pasquale Perrone Filardi, will focus on�Hormonal and Metabolic Abnormalities in Heart Failure Patients. This issue is one of four selected for the year by the series Consulting Editor,�Eduardo Bossone. Topics include, but are not limited to,�Glucose metabolism abnormalities in heart failure patients, Diabetic cardiomyopathy,�New oral antidiabetics in chronic heart failure,�Metabolic syndrome and heart failure,�Eritropoietin anemia and iron vs. exercise capacity in chronic heart failure,�Prognostic value of hormonal abnormalities in heart failure patients,�Hormonal Replacement Therapy in Heart Failure,�The management of thyroid abnormalities in chronic heart failure,�Acromegaly and heart failure,�Beta-receptor signaling and heart failure,�and Evaluation of cardiac metabolism by magnetic resonance spectroscopy in heart failure.

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.